bromamine acid: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 22628 |
| CHEMBL ID | 1206406 |
| SCHEMBL ID | 3181034 |
| MeSH ID | M0231545 |
| Synonym |
|---|
| c14h8brno5s |
| 1-amino-4-bromo-9,10-dioxo-2-anthracenesulfonic acid sodium salt |
| 1-amino-4-bromo-9,10-dioxo-2-anthracenesulfonic acid |
| nsc7574 |
| 116-81-4 |
| bromaminic acid |
| alizarine cyanol grey g |
| nsc-7574 |
| 1-amino-4-bromo-2-anthraquinonesulfonic acid, sodium salt acid |
| bromamine acid |
| 1-amino-4-bromo-9,10-dioxo-9,10-dihydro-anthracene-2-sulfonic acid |
| 1-amino-4-bromo-2-anthraquinone sulfonic acid |
| AKOS001595036 |
| 1-amino-4-bromo-9,10-dioxoanthracene-2-sulfonic acid |
| 1-amino-4-bromo-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid |
| nsc 7574 |
| 2-anthracenesulfonic acid, 1-amino-4-bromo-9,10-dihydro-9,10-dioxo- |
| alizarine cyanol grey g (van) |
| 1-amino-4-bromo-9,10-dioxoanthracene-2-sulphonic acid |
| unii-sbz7fun4bk |
| sbz7fun4bk , |
| 1-amino-4-bromo-2-anthraquinonesulfonic acid |
| einecs 204-159-9 |
| 2-anthracenesulfonic acid, 1-amino-4-bromo- |
| 1-amino-4-bromo-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid |
| NCGC00256168-01 |
| cas-116-81-4 |
| dtxsid5044782 , |
| dtxcid3024782 |
| tox21_301752 |
| FT-0607325 |
| 1-amino-4-bromoanthraquinone-2-sulphonic acid |
| SCHEMBL3181034 |
| 1-amino-4-bromo-anthraquinone-2-sulphonic acid |
| 1-amino-4-bromo-2-sulfoanthraquinone |
| QZZSAWGVHXXMID-UHFFFAOYSA-N |
| 1-amino-4-bromoanthraquinone-2-sulfonic acid |
| CHEMBL1206406 |
| 1-amino-2-sulfonato-4-bromo-9,10-anthraquinone |
| 2-anthraquinonesulfonic acid, 1-amino-4-bromo- |
| STL428864 |
| BBL034687 |
| AC-10116 |
| W-108576 |
| 1-amino-4-bromoanthraquinone-2-sulfonicacid |
| mfcd00035694 |
| bromamine acid, aldrichcpr |
| SR-01000080160-1 |
| sr-01000080160 |
| 1-amino-4-bromo-9,10-dioxo-9,10-dihydroanthracene-2-sulfonicacid |
| AS-49393 |
| SB30935 |
| Q27289131 |
| I10009 |
| bromaminic acid; |
| CS-0010173 |
| SY110479 |
| Excerpt | Relevance | Reference |
|---|---|---|
| " The results showed that in an acidic environment the supported nZVI with a dosage of 2 g/L showed high activity in the degradation of bromamine acid with an initial concentration of 1,000 mg/L, and the degree of decolorization could reach up to 98%." | ( Degradation of bromamine acid by nanoscale zero-valent iron (nZVI) supported on sepiolite. Cao, L; Fei, X; Gu, Y; Wang, X; Zhou, L, 2012) | 0.94 |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| Luciferase | Photinus pyralis (common eastern firefly) | Potency | 35.5742 | 0.0072 | 15.7588 | 89.3584 | AID1224835 |
| estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 68.5896 | 0.0006 | 57.9133 | 22,387.1992 | AID1259377 |
| nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 5.4483 | 0.0010 | 22.6508 | 76.6163 | AID1224838; AID1224893 |
| retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 5.8197 | 0.0008 | 17.5051 | 59.3239 | AID1159531 |
| estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 36.9828 | 0.0015 | 30.6073 | 15,848.9004 | AID1224848; AID1224849; AID1259403 |
| pregnane X nuclear receptor | Homo sapiens (human) | Potency | 48.5577 | 0.0054 | 28.0263 | 1,258.9301 | AID1346982 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 43.6412 | 0.0002 | 29.3054 | 16,493.5996 | AID743075 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 38.8952 | 0.0237 | 23.2282 | 63.5986 | AID743241 |
| aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 28.9719 | 0.0007 | 23.0674 | 1,258.9301 | AID743085; AID743122 |
| thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 63.5221 | 0.0016 | 28.0151 | 77.1139 | AID1259395 |
| thyrotropin-releasing hormone receptor | Homo sapiens (human) | Potency | 34.6713 | 0.1549 | 17.8702 | 43.6557 | AID1346891 |
| Histone H2A.x | Cricetulus griseus (Chinese hamster) | Potency | 50.4772 | 0.0391 | 47.5451 | 146.8240 | AID1224845 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 54.4827 | 0.0003 | 23.4451 | 159.6830 | AID743065; AID743067 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 21.6899 | 0.0006 | 27.2152 | 1,122.0200 | AID743219 |
| Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 68.5896 | 0.0023 | 19.5956 | 74.0614 | AID651631 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1055905 | Cytotoxicity against human NCI-H157 cells at 100 uM after 24 hrs by sulforhodamine B assay | 2013 | European journal of medicinal chemistry, , Volume: 70 | Identification of sulfonic acids as efficient ecto-5'-nucleotidase inhibitors. |
| AID1055906 | Inhibition of rat recombinant ecto-5'-nucleotidase expressed in african green monkey COS7 cells using adenosine monophosphate as substrate at 1 mM preincubated for 10 mins before substrate addition measured after 10 mins by capillary electrophoresis | 2013 | European journal of medicinal chemistry, , Volume: 70 | Identification of sulfonic acids as efficient ecto-5'-nucleotidase inhibitors. |
| AID1055903 | Cytotoxicity against HCEC after 24 hrs by sulforhodamine B assay | 2013 | European journal of medicinal chemistry, , Volume: 70 | Identification of sulfonic acids as efficient ecto-5'-nucleotidase inhibitors. |
| AID1055907 | Inhibition of human recombinant ecto-5'-nucleotidase expressed in african green monkey COS7 cells using adenosine monophosphate as substrate at 1 mM preincubated for 10 mins before substrate addition measured after 10 mins by capillary electrophoresis | 2013 | European journal of medicinal chemistry, , Volume: 70 | Identification of sulfonic acids as efficient ecto-5'-nucleotidase inhibitors. |
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | 2014 | Journal of biomolecular screening, Jul, Volume: 19, Issue:6 | A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum. |
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | |||
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (27.09) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 15 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||